Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00148954 · ClinicalTrials.gov registry record · Phase 4
RIGHT: Rhythm ID Going Head-to-Head Trial
A Phase 4 study of Tachycardia, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,962
- Enrollment target
- 1
- Study location
NCT00148954: Completed Phase 4 study of Tachycardia, sponsored by Boston Scientific Corporation.
NCT00148954 is a Phase 4 study of Tachycardia that has completed, run by Boston Scientific Corporation. The registered enrollment target is 1,962 participants, above the 653-participant average among 8 other Tachycardia trials with a reported enrollment target (200% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00148954, a Phase 4 study of Tachycardia, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,962 participants
- Enrollment target
- 1
- Study location
Study Summary
RIGHT is a randomized, prospective, two-arm study that will assess the differential efficacy of VITALITY 2 implantable cardioverter defibrillators (ICDs) using Rhythm ID™ versus selected Medtronic ICDs.
Primary Outcome
An inappropriate therapy is defined as a VT/VF therapy, either shock or antitachycardia pacing (ATP), delivered for a supraventricular tachycardia (SVT). All events for which a VT/VF therapy was delivered and a stored electrogram exists were reviewed by an independent adjudication committee to determine the appropriateness of device rhythm classification and subsequent therapy delivery.
Conditions Studied
Interventions
- DEVICE VITALITY 2 Implantable Cardioverter Defibrillator
- DEVICE Medtronic Implantable Cardioverter Defibrillator
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,962 participants |
| Start Date | 2005-07 |
| Est. Completion | 2010-07 |
| Phase | Phase 4 |
What the finished NCT00148954 record still lists
NCT00148954 is an interventional study that assigns participants to a tested intervention. Its 1,962 participants enrollment target places it among the larger protocols in the corpus, above the 653-participant average among 8 other Tachycardia trials with a reported enrollment target (200% higher).
The record links to 1 condition, with Tachycardia appearing as the primary indexed condition, and to 2 interventions - of which VITALITY 2 Implantable Cardioverter Defibrillator is the first listed.
NCT00148954 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT00148954 about?
NCT00148954 is a clinical study titled "RIGHT: Rhythm ID Going Head-to-Head Trial". RIGHT is a randomized, prospective, two-arm study that will assess the differential efficacy of VITALITY 2 implantable cardioverter defibrillators (ICDs) using Rhythm ID™ versus selected Medtronic ICDs.
What is the current status of trial NCT00148954?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,962 participants. The study started on 2005-07. Estimated completion is 2010-07.
What conditions does trial NCT00148954 study?
This clinical trial studies the following conditions: Tachycardia.
What interventions are being tested in trial NCT00148954?
The interventions under investigation include: VITALITY 2 Implantable Cardioverter Defibrillator (DEVICE), Medtronic Implantable Cardioverter Defibrillator (DEVICE).
Who is sponsoring clinical trial NCT00148954?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00148954 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tachycardia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00148954's enrollment target sits among peer trials
1,962 1st of 8 higher than 8 of 8 other Tachycardia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tachycardia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Optimal Anti-tachycardia Therapy in Implantable Cardioverter-defibrillator (ICD) Patients Without Pacing Indications
COMPLETED · Phase 4
-
TriVerity™ for Improved Management of Emergency Department (ED) Patients With Suspected Infections
RECRUITING · NA
-
Treatment of Orthostatic Intolerance
ACTIVE NOT RECRUITING · Phase 1
-
Detection and Classification of Cardiac Rhythm and Atrial Fibrillation Using a Finger-worn Ring
ACTIVE NOT RECRUITING
-
Enlighten Study: The EV-ICD Post Approval Registry
ACTIVE NOT RECRUITING
-
Pathophysiology of Orthostatic Intolerance
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04251052 · 1,956 participants · NA
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
- NCT06062394 · 1,980 participants · NA
Penn Medicine Healthy Heart
- NCT07321886 · 1,980 participants · Phase 3
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- NCT05233150 · 1,932 participants · NA
Child-Adult Relationship Enhancement in Primary Care (PriCARE) / Criando Niños Con CARIÑO (CARIÑO)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia